A Study of ES009 in Subjects With Locally Advanced or Metastatic Solid Tumors
Clinical trial NCT06007482 · COMPLETED
Trial details
- NCT number
- NCT06007482
- Sponsor
- Elpiscience Biopharma Australia Pty. Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-26
- Primary completion
- 2025-02-18
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.